{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT01779362","recordId":"NCT01779362","peptideSlug":"liraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01779362-liraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct01779362.json","markdown":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct01779362.md"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2013-01-28","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2013-01-28","publishedAt":"2026-08-23","recordId":"NCT01779362","recordSha256":"7cc9503156a26812850fb9c37382e0df857d0d15a6c11dd0dbe62e3334f06253","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01779362?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2013-05-23","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2013-05-23","publishedAt":"2026-08-23","recordId":"NCT01779362","recordSha256":"6eac169e950e38c71a3529532d17eda56637c592b942a09385cdda930fcc19fc","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01779362?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2013-12-19","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2013-12-19","publishedAt":"2026-08-23","recordId":"NCT01779362","recordSha256":"9d8a3768f0ec4c71f66c608c5031e75a3004385f27390ae4857cec637a2b6c35","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01779362?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Eligibility","Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2014-11-05","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2014-11-05","publishedAt":"2026-08-23","recordId":"NCT01779362","recordSha256":"86149152757b4679c98f1b7f3e0b3235213aa8a9d86cb46472564ce7d2423d63","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01779362?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2015-07-16","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2015-07-16","publishedAt":"2026-08-23","recordId":"NCT01779362","recordSha256":"a71c549897d1911b03664d6b91cd73f123421ade35d3470708a4d47843fc29d7","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01779362?a=5&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Arms and Interventions","Study Status"],"historyVersion":6,"lastUpdateSubmitQcDate":"2015-10-26","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2015-10-26","publishedAt":"2026-08-23","recordId":"NCT01779362","recordSha256":"a7b473d5bf900480ee401ecc767d1078a44b85a2f0447212c8a6af6802d36e7d","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01779362?a=6&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":7,"lastUpdateSubmitQcDate":"2016-04-04","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2016-04-04","publishedAt":"2026-08-23","recordId":"NCT01779362","recordSha256":"cecd2dd18deef48ce06d284c2a38aa263114d5974a72cbed9d4a26bd7f1961b9","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01779362?a=7&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","IPDSharing","Study Status"],"historyVersion":8,"lastUpdateSubmitQcDate":"2017-04-03","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2017-04-03","publishedAt":"2026-08-23","recordId":"NCT01779362","recordSha256":"b9a1c6f661889b71fc7ae2b65a22f57e63e7e34c05ab3df97678992d665a17da","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01779362?a=8&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","References","Study Design","Study Status"],"historyVersion":9,"lastUpdateSubmitQcDate":"2018-08-29","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2018-08-29","publishedAt":"2026-08-23","recordId":"NCT01779362","recordSha256":"c512eabe4ebc6dcb6d5cae5cc624d393010341bd3f348e9dc1083202c7583825","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01779362?a=9&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Adverse Events","Baseline Characteristics","Document Section","More Information","Outcome Measures","Outcome Measures (Results)","Participant Flow","Study Status"],"historyVersion":10,"lastUpdateSubmitQcDate":"2023-04-12","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2023-04-12","publishedAt":"2026-08-23","recordId":"NCT01779362","recordSha256":"774ca6399dcc65f888782caa191b18e05e6818523309ef404c1778e6a66278c5","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01779362?a=10&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"79f53dad737fe2da8058845fc14bc4e3a2aae05b5e1ca8204621c2bf4794bcad"}}